Novartis invests further $15m into Gamida Cell
October 13, 2015Research and Development, Sales and Marketing Gamida Cell, Novartis, pharma mergers and acquisitions
Novartis is to invest an extra $15 million into Israeli stem cell therapy developer Gamida Cell, adding an additional 2.5% …
Stefan Oschmann promoted to top job at Merck KGaA
October 13, 2015Manufacturing and Production, Research and Development, Sales and Marketing Merck KGaA, Stefan Oschmann
Merck KGaA has announced the promotion of its deputy chief executive, Stefan Oschmann, to the role of chief executive, starting …
NICE launches new service to speed NHS adoption of health technologies
October 13, 2015Manufacturing and Production, Research and Development, Sales and Marketing NHS, NICE, OMA, market access, office for market access
NICE is introducing a new service, the Office for Market Access (OMA), to work with industry to speed up NHS …
Contact manufacturing ‘is changing the industry’, report finds
October 13, 2015Manufacturing and Production CMO, contract manufacturing, manufacturing, pharma, production
The global market for pharma and biopharma contract manufacturing is expected to reach more than €332.7 billion by 2018, according …
Berg interview: artificial intelligence and big data join the war on disease
October 13, 2015Medical Communications, Research and Development AI, Berg, Big Data, genomics
Boston-based biopharmaceutical company Berg recently announced it joined an industry collaboration with Genomics England, set up by UK Prime Minister …
AstraZeneca halts lung cancer trials amidst safety concerns
October 13, 2015Manufacturing and Production AZD9291, AstraZeneca, MEDI4736, NSCLC, drug safety, durvalumab, interstitial lung disease, lung cancer, non-small cell lung cancer
AstraZeneca is stopping two trials of a combination of two of its pipeline cancer treatments, after reports that the pairing …
Merck improves manufacturing program
October 13, 2015Manufacturing and Production Merck, Merck Millipore, manufacturing, production
Merck Millipore, the life science business arm of Merck KGaA, has introduced enhancements to its Emprove portfolio of raw pharmaceutical …
Lilly shares fall as company abandons evacetrapib development
October 13, 2015Manufacturing and Production evacetrapib, high cholesterol, lilly, phase III, phase III failure
Eli Lilly shares fell by nearly 8% this week as the company announced it will abandon developmenty of the investigational …
Blow for Scottish women as SMC rejects Afinitor for advanced breast cancer
October 12, 2015Sales and Marketing SMC, advanced breast cancer
The Scottish Medicines Consortium (SMC) has announced that it will not recommend Novartis’s Afinitor (everolimus) for use in advanced breast …
New cancer medicines approved in Scotland, available via NHS
October 12, 2015Sales and Marketing Scottish Medicines Consortium, Zytiga, abiraterone acetate, prostate cancer
The Scottish Medicines Consortium (SMC) has today recommended Janssen’s Zytiga (abiraterone acetate) for use before chemotherapy in men with advanced …
Health professionals back transparency of their dealings with pharma
October 12, 2015Research and Development, Sales and Marketing ABPI, transparency
The majority of doctors, nurses, hospital specialists and pharmacists believe that payments received by healthcare professionals (HCPs) from pharmaceutical companies …
Time for pharma to think big on genomics research
October 12, 2015Research and Development Sir John Chisholm, genomics
Sir John Chisholm, executive chair of Genomics England, is very clear about what the project he is overseeing is – …
Obama’s FDA nominee criticised for big pharma ties
October 12, 2015Sales and Marketing Bernie Sanders, Dr Robert Califf, FDA
Democratic presidential nomination candidate Senator Bernie Sanders has criticised President Obama’s choice for the next FDA commissioner, as a result …
Pfizer wins Zoloft birth defects lawsuit
October 12, 2015Sales and Marketing Pfizer, Zoloft, birth defects, lawsuits, sertraline
Judges in the US have dismissed a lawsuit against Pfizer that had claimed that the use of its antidepressant Zoloft during pregnancy …
MSD’s Keytruda receives green light from NICE for NHS use
October 12, 2015Sales and Marketing MSD, Merck, NICE, keytruda, melanoma, pembrolizumab, skin cancer
The UK healthcare watchdog NICE has recommended Keytruda as a treatment for advanced skin cancer – its second endorsement of …
Novartis psoriasis drug shows three-year efficacy
October 12, 2015Cosentyx, EADV, Novartis, Secukinumab, psoriasis
Novartis has announced new trial data confirming the efficacy of Cosentyx in patients with moderate-to-severe plaque psoriasis. The results of …
How can pharma succeed in emerging markets?
October 10, 2015Sales and Marketing GSK, Pfizer
In recent years, the major pharma companies have been forced to react to the maturation and cost-cutting, plus regulatory pressures, …
Biogen reports on Tecfidera multiple sclerosis clinical trials
October 9, 2015Research and Development
Biogen has presented data demonstrating the efficacy and safety of Tecfidera (dimethyl fumarate) across a broad range of people with …
Almirall presents new data on cannabinoid-based MS treatment
October 9, 2015Research and Development Almirall, multiple sclerosis
Almirall has presented new clinical evidences of Sativex, the only medicine derived from cannabinoids to treat spasticity symptoms in MS, …
EMA appoints Guido Rasi as executive director
October 9, 2015Medical Communications, Sales and Marketing EMA, Guido Rasi
The European Medicines Agency’s (EMA’s) Management Board has nominated Professor Guido Rasi as the Executive Director of the Agency. The …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
